There were 697 press releases posted in the last 24 hours and 429,635 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Cocrystal Pharma Commences Enrollment and Initiates Patient Dosing in Phase 2a Study Evaluating CC-31244 for the Treatment of HCV

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image